Page last updated: 2024-08-24

triazoles and Pulmonary Aspergillosis

triazoles has been researched along with Pulmonary Aspergillosis in 97 studies

Research

Studies (97)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (11.34)29.6817
2010's70 (72.16)24.3611
2020's16 (16.49)2.80

Authors

AuthorsStudies
Eller, P; Gorkiewicz, G; Hatzl, S; Hoenigl, M; Krause, R; Metnitz, P; Pilz, S; Posch, F; Prattes, J; Prüller, F; Reisinger, AC; Rief, M; Rosenkranz, AR; Schilcher, G; Schoerghuber, M; Stradner, M; Toller, W; Valentin, T1
Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE1
Cai, L; Chen, C; Dai, C; Gao, P; Ilkit, M; Ning, Y; Wang, Z; Xiao, J; Xue, X1
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M1
Armstrong-James, D; Bromley, M; Kosmidis, C1
Bellomo, R; Costa-Pinto, R; Finlay, L; Klink, S; Perera, P; Rotherham, H; Trubiano, J; Urbancic, K; Vaz, K1
Bellanger, AP; Berceanu, A; Daguindau, E; Desbrosses, Y; Millon, L; Rocchi, S; Scherer, E1
Arikan-Akdagli, S; Dogan, R; Gülmez, D; Karcioglu, O; Selcuk, ZT; Tokat, F; Uzun, O1
Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS1
Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A1
Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL1
Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP1
Chen, W; Li, R; Liang, T; Liu, W; Osherov, N; Wan, Z; Wang, Q; Yang, E; Yang, X1
Ben-Ami, R; Handelman, M; Liu, W; Morogovsky, A; Osherov, N1
Barcelo-Vidal, J; Carballo, N; Conde-Estévez, D; De-Antonio Cuscó, M; Echeverria-Esnal, D; Ferrández, O; Grau, S; Horcajada, JP; Martín-Ontiyuelo, C; Navarrete-Rouco, ME1
Beishuizen, A; Cornet, AD; Masselink, JB; Mian, P; Sportel, ET; Trof, RJ1
Chang, D; McHardy, I; Semrad, A; Thompson, GR; Wittenberg, RR1
Harris, C; Morales, MK; Shoham, S1
Bedin Denardi, L; de Azevedo, MI; Hartz Alves, S; Keller, JT; Morais Santurio, J; Oliveira, V; Pantella Kunz de Jesus, F; Weiblen, C1
Chen, J; Qian, L; Shen, J; Yang, X; Zhang, Y1
Denning, DW; Harris, C; Kosmidis, C; Muldoon, EG; Newton, PJ; Rodriguez-Goncer, I1
Della Pepa, R; Giordano, C; Grimaldi, F; Mortaruolo, C; Pane, F; Picardi, M; Pugliese, N; Raimondo, M; Salvatore, P; Sirignano, C; Trastulli, F; Zacheo, I1
Abdallah, N; Kanj, A; Soubani, AO1
Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R1
Denning, DW; Kosmidis, C; Moore, CB; Rautemaa-Richardson, R; Richardson, MD; Rodriguez-Goncer, I1
Castagnola, E; De Leonardis, F; Giannico, B; Mariggiò, MA; Novielli, C; Santoro, N1
Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sehra, G; Strong, P1
Alanio, A; Bretagne, S; Chowdhary, A; Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Meis, JF; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sharma, C; Strong, P1
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H1
Campoli, C; Capone, A; Chiappetta, D; Chinello, P; Di Bella, S; Petrosillo, N1
El-Sherief, A; Gordon, S; Olbrych, T; Tedja, R1
Fox, DA; Gladue, HS1
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M1
Bucknor, MD; Gross, AJ; Link, TM1
Ando, T; Kawashima, M; Koyama, K; Matsui, H; Nagai, H; Ohshima, N; Ohta, K; Sato, R; Suzuki, J; Takeda, K1
Chan, T; Ding, WY; McWilliams, R; Yadavilli, RK1
Ahmad, S; Joseph, L; Khan, Z1
Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G1
Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y1
Cadranel, J; Cateau, E; Frat, JP; Godet, C; Goudet, V; Gounant, V; Laurent, F; Le Moal, G; Roblot, F1
Cheng, MP; Parkes, LO; Sheppard, DC1
Buitrago, MJ; Cendejas-Bueno, E; Forastiero, A; Gavaldà, J; Gomez-Lopez, A; Mellado, E; Ruiz, I1
Barao Ocampo, M; Biffi, A; Colombo, C; De Lorenzis, G; Esposto, MC; Favuzzi, V; Koncan, R; Lo Cascio, G; Pizzamiglio, G; Prigitano, A; Romanò, L; Tortorano, AM1
Al-Shair, K; Denning, DW; Harris, C; Lowes, D; Morris, J; Newton, PJ; Rautemaa-Richardson, R1
Iseman, MD; Peloquin, CA; Schwiesow, JN1
Kanazawa, K; Niki, Y; Takemoto, K; Ueda, Y; Yamamoto, Y; Yoshida, K1
Baba, T; Endo, T; Enomoto, T; Hagiwara, E; Kato, T; Komatsu, S; Matsushima, A; Nishihira, R; Ogura, T; Sekine, A; Shiihara, J; Shinohara, T; Sogo, Y; Tagawa, A; Takahashi, H; Tsuchiya, N1
Maertens, J; Meersseman, W; Van Bleyenbergh, P1
Ayats, J; Fernández, N; Gasch, O; Santin, M1
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ1
Han, FC; Jureen, R; Tew, CW; Tey, BH1
Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY1
Alffenaar, JW; Daenen, SM; Kosterink, JG; Uges, DR; van der Elst, KC1
Altman, R; Belperio, JA; Eshaghian, P; Gregson, A; Kubak, B; Lynch, JP; Ross, DJ; Saggar, R; Wang, T; Wang, TF; Weigt, SS1
Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H1
Duval, A; Hickman, G; Petit, A; Picard, C1
Wingard, J1
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J1
Chudgar, SM; Norton, BL; Person, AK; Stout, JE; Tong, BC1
Segal, BH; Sherif, R1
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T1
Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS1
Meersseman, W1
Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E1
Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N1
Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH1
Izumikawa, K; Kohno, S1
Baxter, C; Denning, DW; Felton, TW; Hope, WW; Moore, CB; Roberts, SA1
Bierings, MB; Melchers, WJ; Thors, VS; Verweij, PE; Wolfs, TF1
Ayub, A; Kenney, CV; McKiernan, FE1
Bedouch, P; Belaiche, S; Pison, C; Quetant, S; Roustit, M; Saint-Raymond, C1
Kuithan, F; Scheer, F; Wiggermann, P1
Pena, TA; Samavati, L; Soubani, AO1
Hoshika, Y; Kato, M; Katsura, Y; Kikuchi, K; Misawa, S; Nagaoka, T; Ohashi, R; Seyama, K; Sugawara, T; Takahashi, K; Takekawa, H; Togo, S; Tsuchiya, K; Yoshimi, K1
Bowyer, P; Bueid, A; Denning, DW; Fraczek, MG; Gore, R; Kirwan, M; Lass-Florl, C; Moore, CB; Park, S; Perlin, DS; Smith, J1
Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M1
Malfertheiner, MV; Schreiber, J; Waldburg, N1
Bignell, EM; Cairns, T; Doyle, S; Kavanagh, K; Larsen, TO; Miggin, SM; O'Hanlon, KA; O'Keeffe, G; Schrettl, M; Stack, D1
Björkholm, M; Celsing, F; Grane, P; Kalin, M1
Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E1
Chowdhary, A; Gaur, SN; Kathuria, S; Klaassen, CH; Meis, JF; Randhawa, HS1
Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M1
Alcazar-Fuoli, L; Bignell, E; Blatzer, M; Cairns, T; Grimalt, JO; Gründlinger, M; Haas, H; Lopez, JF; Puempel, T; Yasmin, S1
Patterson, TF; Thompson, GR1
Kikuti, K1
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A1
Andersen, CU; Bendstrup, E; Henning, O; Hilberg, O; Lundby, T; Mortensen, J1
Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M1
Debaveye, Y; Grootaert, V; Meyfroidt, G; Spriet, I; Willems, L1
Chandrasekar, PH; Cutright, JL; Krishnan Natesan, S; Wu, W1
Fujiuchi, S; Kato, T; Kawabata, M; Kuba, M; Kurashima, A; Ogawa, K; Saito, T; Sakatani, M; Sasaki, Y; Suzuki, K; Tada, A; Tao, Y1
Buendía, B; Cuenca-Estrella, M; De La Camara, R; Mellado, E; Rodriguez-Tudela, JL1
Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G1
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC1
Del Rosario, RC; Halloush, RA; Khasawneh, FA1
Clauss, H; Samuel, R1

Reviews

13 review(s) available for triazoles and Pulmonary Aspergillosis

ArticleYear
Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Gastrointestinal Microbiome; Humans; Lung; Pulmonary Aspergillosis; Triazoles

2022
Update on the treatment of chronic pulmonary aspergillosis.
    Current opinion in infectious diseases, 2023, 04-01, Volume: 36, Issue:2

    Topics: Antifungal Agents; Cytokines; Echinocandins; Humans; Pulmonary Aspergillosis; Triazoles

2023
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Expert review of respiratory medicine, 2020, Volume: 14, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole

2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
    The Lancet. Infectious diseases, 2021, Volume: 21, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole

2021
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review.
    Expert review of anti-infective therapy, 2022, Volume: 20, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Pulmonary Aspergillosis; Triazoles

2022
Graded isavuconazole introduction in a patient with voriconazole allergy.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:6

    Topics: Amphotericin B; Angioedema; Antifungal Agents; Aspergillus; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Cirrhosis; Liver Transplantation; Lung; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2017
The spectrum of pulmonary aspergillosis.
    Respiratory medicine, 2018, Volume: 141

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Environmental Exposure; Fungi; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Prognosis; Pulmonary Aspergillosis; Pyridines; Recurrence; Triazoles

2018
Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Aged; Antifungal Agents; Chemoprevention; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
    Mycoses, 2015, Volume: 58, Issue:3

    Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus; Contraindications; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Nebulizers and Vaporizers; Pulmonary Aspergillosis; Triazoles

2015
New therapies for fungal pneumonia.
    Current opinion in infectious diseases, 2009, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole

2009
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
    Current opinion in pulmonary medicine, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole

2010
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
    Lung, 2011, Volume: 189, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole

2011
Pulmonary aspergillosis: recent advances.
    Seminars in respiratory and critical care medicine, 2011, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disease Susceptibility; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Opportunistic Infections; Pulmonary Aspergillosis; Triazoles

2011

Trials

3 trial(s) available for triazoles and Pulmonary Aspergillosis

ArticleYear
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole

2023
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
    The Journal of infection, 2010, Volume: 61, Issue:5

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2010
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2012

Other Studies

81 other study(ies) available for triazoles and Pulmonary Aspergillosis

ArticleYear
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Critical care (London, England), 2021, 09-15, Volume: 25, Issue:1

    Topics: Aged; Antifungal Agents; COVID-19; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Pulmonary Aspergillosis; Respiratory Distress Syndrome; Triazoles

2021
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole

2022
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
    Medical mycology, 2023, Jun-05, Volume: 61, Issue:6

    Topics: Animals; Antifungal Agents; COVID-19; Pulmonary Aspergillosis; Retrospective Studies; Triazoles; Voriconazole

2023
Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients.
    Emerging infectious diseases, 2019, Volume: 25, Issue:9

    Topics: Antifungal Agents; Aspergillus fumigatus; Diagnosis, Differential; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Treatment Failure; Triazoles

2019
A Rare Presentation of Pulmonary Aspergillosis: Bronchial Stump Aspergillosis.
    Journal of bronchology & interventional pulmonology, 2020, Volume: 27, Issue:2

    Topics: Aftercare; Antifungal Agents; Aspergillus flavus; Biopsy; Bronchial Diseases; Bronchoscopy; Female; Humans; Lung Diseases, Fungal; Middle Aged; Postoperative Complications; Pulmonary Aspergillosis; Treatment Outcome; Triazoles

2020
COVID-19 associated pulmonary aspergillosis.
    Mycoses, 2020, Volume: 63, Issue:6

    Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole

2020
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    JAMA dermatology, 2020, 07-01, Volume: 156, Issue:7

    Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole

2020
Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
    Antimicrobial agents and chemotherapy, 2021, 06-17, Volume: 65, Issue:7

    Topics: Antifungal Agents; Aspergillus fumigatus; China; Drug Resistance, Fungal; Fungal Proteins; HMGB1 Protein; Humans; Microbial Sensitivity Tests; Mutation; Pulmonary Aspergillosis; Triazoles

2021
Triazole-Resistant Aspergillus fumigatus in an Israeli Patient with Chronic Cavitary Pulmonary Aspergillosis Due to a Novel E306K Substitution in Hmg1.
    Antimicrobial agents and chemotherapy, 2021, 09-17, Volume: 65, Issue:10

    Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Fungal Proteins; HMGB1 Protein; Humans; Pulmonary Aspergillosis; Triazoles

2021
Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
    Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:3

    Topics: Antifungal Agents; COVID-19; Critical Illness; Humans; Pulmonary Aspergillosis; Triazoles

2022
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aged; Antifungal Agents; Cortisone; Humans; Hydrocortisone; Hypertension; Hypokalemia; Lung; Male; Mineralocorticoid Excess Syndrome, Apparent; Pulmonary Aspergillosis; Triazoles

2017
Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:1

    Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lung; Mice; Pulmonary Aspergillosis; Treatment Outcome; Triazoles

2018
Successful Treatment of Lung Aspergillus terreus Infection After a Second Hematopoietic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2019, Volume: 17, Issue:3

    Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Male; Micafungin; Myelodysplastic Syndromes; Postoperative Complications; Pulmonary Aspergillosis; Remission Induction; Triazoles; Young Adult

2019
Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria.
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Salvage Therapy; Surveys and Questionnaires; Survival Analysis; Treatment Outcome; Triazoles

2018
(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations.
    Annals of hematology, 2019, Volume: 98, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Risk Factors; Triazoles; Vidarabine

2019
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Mycoses, 2019, Volume: 62, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole

2019
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
    The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Chronic Disease; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Tablets; Treatment Outcome; Triazoles

2019
Isavuconazole Treatment of Cerebral and Pulmonary Aspergillosis in a Pediatric Patient With Acute Lymphoblastic Leukemia: Case Report and Review of Literature.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:6

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Child, Preschool; Female; Humans; Neuroaspergillosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pulmonary Aspergillosis; Pyridines; Triazoles

2020
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
    Scientific reports, 2019, 07-01, Volume: 9, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Benzamides; Cell Line; Drug Synergism; Humans; Pulmonary Alveoli; Pulmonary Aspergillosis; Triazoles; Voriconazole

2019
Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Animals; Antifungal Agents; Aspergillus; Colony Count, Microbial; Disease Models, Animal; France; Galactose; Humans; India; Lung; Mannans; Mice; Microbial Sensitivity Tests; Netherlands; Pulmonary Aspergillosis; Treatment Outcome; Triazoles

2019
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
    BMC infectious diseases, 2013, Feb-26, Volume: 13

    Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2013
Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.
    Mycopathologia, 2013, Volume: 175, Issue:3-4

    Topics: Aged; Antifungal Agents; Humans; Lung; Male; Mycetoma; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2013
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2013, Volume: 19, Issue:8

    Topics: Aged; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Diagnosis, Differential; Disease Progression; Female; Granulomatosis with Polyangiitis; Hip Joint; Humans; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
    Mycopathologia, 2014, Volume: 177, Issue:1-2

    Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole

2014
Voriconazole-induced periostitis in two post-transplant patients.
    Journal of radiology case reports, 2013, Volume: 7, Issue:8

    Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Pulmonary Aspergillosis; Recurrence; Retrospective Studies; Risk Factors; Substance Withdrawal Syndrome; Triazoles

2014
Aspergilloma and massive haemoptysis.
    BMJ case reports, 2014, Apr-16, Volume: 2014

    Topics: Adult; Aneurysm, False; Angiography; Antifungal Agents; Embolization, Therapeutic; Female; Hemoptysis; Humans; Ill-Housed Persons; Mycetoma; Pulmonary Artery; Pulmonary Aspergillosis; Pyrimidines; Severity of Illness Index; Substance Abuse, Intravenous; Tomography, X-Ray Computed; Triazoles; Voriconazole

2014
Aerial prevalence of Aspergillus calidoustus isolates in and around a tertiary care hospital in Kuwait and assessment of their pathogenicity.
    Journal of clinical microbiology, 2014, Volume: 52, Issue:9

    Topics: Air Microbiology; Animals; Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; DNA, Fungal; Humans; Kuwait; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pulmonary Aspergillosis; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles

2014
Invasive cardiac aspergillosis after orthotopic liver transplantation.
    Zeitschrift fur Gastroenterologie, 2014, Volume: 52, Issue:8

    Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles

2014
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2014, Volume: 88, Issue:4

    Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2014
Visual Hallucinations Associated with High Posaconazole Concentrations in Serum.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:2

    Topics: Aged; Antifungal Agents; Female; Hallucinations; Humans; Pulmonary Aspergillosis; Treatment Outcome; Triazoles

2016
Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis.
    Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34, Issue:9

    Topics: Animals; Antifungal Agents; Biomarkers; Galactose; Immunoenzyme Techniques; Mannans; Pulmonary Aspergillosis; Rats; Real-Time Polymerase Chain Reaction; Triazoles

2016
Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2017, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillus fumigatus; Child; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Environment; Female; Fungal Proteins; Humans; Italy; Male; Microbial Sensitivity Tests; Point Mutation; Prevalence; Pulmonary Aspergillosis; Triazoles

2017
Predictors of mortality in chronic pulmonary aspergillosis.
    The European respiratory journal, 2017, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; C-Reactive Protein; Chronic Disease; Female; Humans; Lung; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Risk Factors; Serum Albumin, Human; Survival Analysis; Triazoles; United Kingdom; Young Adult

2017
Concomitant use of voriconazole and rifabutin in a patient with multiple infections.
    Pharmacotherapy, 2008, Volume: 28, Issue:8

    Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole

2008
Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
    Chemotherapy, 2009, Volume: 55, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Lung; Male; Mice; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
[Usefulness of monitoring plasma voriconazole concentration in patients with chronic necrotizing pulmonary aspergillosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole

2009
Aspergillus vertebral osteomyelitis and epidural abscess.
    Singapore medical journal, 2009, Volume: 50, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole

2009
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
    Thorax, 2009, Volume: 64, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole

2009
Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:3

    Topics: Anticonvulsants; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Phenytoin; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:12

    Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; Lung Transplantation; Male; Middle Aged; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
    Medical mycology, 2010, Volume: 48, Issue:1

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2010
[Porphyria cutanea tarda revealed by voriconazole].
    Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:1

    Topics: Aged; Alcoholism; Antifungal Agents; Cheilitis; Feces; Humans; Liver; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Uroporphyrinogen Decarboxylase; Voriconazole

2010
Antifungal management.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.
    Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 7

    Topics: Aged; Antifungal Agents; Aspergillus niger; Female; Humans; Lung; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12

    Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Pediatric pulmonology, 2010, Volume: 45, Issue:7

    Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole

2010
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
    Pediatric hematology and oncology, 2010, Volume: 27, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
Case report 2: Fungal infections in chronic obstructive pulmonary disease.
    Mycoses, 2010, Volume: 53 Suppl 2

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Belgium; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography, Thoracic; Steroids; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
    Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 12

    Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Pulmonary aspergillosis in a non-neutropenic critical patient.
    The Journal of trauma, 2010, Volume: 69, Issue:4

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-15, Volume: 51, Issue:12

    Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Humans; Pulmonary Aspergillosis; Treatment Outcome; Triazoles

2010
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-15, Volume: 51, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Radiography, Thoracic; Retrospective Studies; Serum; Treatment Failure; Treatment Outcome; Triazoles

2010
Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Chemoprevention; Child; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole

2011
Management of voriconazole hepatotoxicity in a lung transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:3

    Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Transplantation; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
[Fatal outcome of invasive tracheal aspergillosis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2011, Volume: 183, Issue:5

    Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult

2011
Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS).
    Medical mycology journal, 2011, Volume: 52, Issue:1

    Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Paraproteinemias; Pulmonary Aspergillosis; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2011
High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 52, Issue:9

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Chronic Disease; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Humans; Invasive Pulmonary Aspergillosis; Lung; Mutation; Polymerase Chain Reaction; Pulmonary Aspergillosis; Sputum; Triazoles

2011
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2011
[Intralobar pulmonary sequestration with aspergillosis in an asymptomatic 39-year-old man].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:22

    Topics: Adult; Bronchopulmonary Sequestration; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Radiography; Thoracotomy; Treatment Outcome; Triazoles; Voriconazole

2011
Targeted disruption of nonribosomal peptide synthetase pes3 augments the virulence of Aspergillus fumigatus.
    Infection and immunity, 2011, Volume: 79, Issue:10

    Topics: Animals; Animals, Outbred Strains; Antifungal Agents; Aspergillus fumigatus; Cell Line; Fungal Proteins; Gene Deletion; Macrophages; Mice; Moths; Peptide Synthases; Phenotype; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Virulence; Voriconazole

2011
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
    Infection, 2012, Volume: 40, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Voriconazole-induced QT interval prolongation and torsades de pointes.
    Pediatrics international : official journal of the Japan Pediatric Society, 2011, Volume: 53, Issue:5

    Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole

2011
Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Cluster Analysis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology; Triazoles

2012
[Pulmonary aspergillosis and HIV infection: about two cases].
    Revue de pneumologie clinique, 2012, Volume: 68, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole

2012
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Feb-21, Volume: 109, Issue:8

    Topics: Amphotericin B; Animals; Aspergillus fumigatus; Biomass; Biosynthetic Pathways; Enoyl-CoA Hydratase; Ergosterol; Ferric Compounds; Gene Deletion; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Fungal; Hydroxamic Acids; Hydroxymethylglutaryl CoA Reductases; Iron Deficiencies; Ligases; Lovastatin; Mevalonic Acid; Mice; Microbial Sensitivity Tests; Oxidative Stress; Pulmonary Aspergillosis; Pyrimidines; Siderophores; Triazoles; Up-Regulation; Virulence; Voriconazole

2012
[Photo quiz: Deep-seated mycosis].
    Medical mycology journal, 2012, Volume: 53, Issue:2

    Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Polymerase Chain Reaction; Pulmonary Aspergillosis; Pyrimidines; RNA, Fungal; Scedosporium; Sputum; Triazoles; Voriconazole

2012
Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pulmonary Aspergillosis; Time Factors; Triazoles

2012
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis.
    The European respiratory journal, 2012, Volume: 40, Issue:1

    Topics: Administration, Inhalation; Aged; Antifungal Agents; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2012
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:3

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2013
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Mice; Mice, Inbred ICR; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
    Infection, 2012, Volume: 40, Issue:6

    Topics: Aged; Antifungal Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
    Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Point Mutation; Postoperative Complications; Pulmonary Aspergillosis; Recurrence; Spain; Species Specificity; Transplantation Conditioning; Transplantation, Homologous; Triazoles

2013
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole

2012
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
    Mycoses, 2013, Volume: 56, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
A 56-year-old man with undifferentiated fever in the ICU and endobronchial plaques.
    Chest, 2013, Feb-01, Volume: 143, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Colectomy; Fever; Humans; Intensive Care Units; Intestinal Diseases; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Simultaneous mold infections in an orthotopic heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:5

    Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole

2008